Ben Goldacre Makes the Case for Greater Transparency in Clinical Trials
Add bookmark
Ben Goldacre Makes the Case for Greater Transparency in Clinical Trials
Add bookmark
"Clinical trial information is being routinely and legally witheld and this needs to end". This is the assertion of Dr. Ben Goldacre; a doctor, science writer, campaigner on scientific issues including clinical trial transparency and author of the book Bad Pharma. Pharma IQ discussed the issue of clinical trial transparency with Dr. Goldacre, with a focus on how it will affect industry and why pharma companies have taken differing strategies in response to the campaign. Have Your Say...
Tags:
clinical trial transparency
Ben Goldacre
Bad Pharma
Bad Science
EMA
clinicaltrials.gov
pharma transparency
